Yayın:
Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorÇağlar, Hale Başak
dc.contributor.authorTurna, Menekşe
dc.contributor.authorYasemin Bölükbaşı
dc.contributor.authorE. Tezcanli
dc.contributor.authorYıldız Güney
dc.contributor.authorFazilet Öner Dinçbaş
dc.contributor.authorBeste M. Atasoy
dc.contributor.authorGamze Uğurluer
dc.contributor.authorHale Başak Çağlar
dc.contributor.authorBanu Atalar
dc.contributor.authorEnis Özyar
dc.contributor.orcid0000-0001-6029-1995
dc.contributor.orcid0000-0001-7464-7307
dc.contributor.orcid0000-0002-3170-5826
dc.contributor.orcid0000-0003-2251-3571
dc.contributor.orcid0000-0002-4764-9419
dc.contributor.orcid0000-0003-1320-9105
dc.contributor.orcid0000-0002-3357-1753
dc.contributor.orcid0009-0001-4800-0064
dc.contributor.orcid0000-0001-8435-8074
dc.contributor.orcid0000-0002-9497-7976
dc.date.accessioned2025-11-13T09:51:57Z
dc.date.issued2024-07-30
dc.identifier.doihttps://doi.org/10.1186/s12885-024-12643-6
dc.identifier.endpage918
dc.identifier.issn1471-2407
dc.identifier.issue1
dc.identifier.openalexW4401123170
dc.identifier.startpage918
dc.identifier.urihttps://hdl.handle.net/11421/2427
dc.identifier.urihttps://doi.org/10.1186/s12885-024-12643-6
dc.identifier.volume24
dc.language.isoen
dc.relation.ispartofBMC Cancer
dc.rightsopenAccess
dc.subjectMedicine
dc.subjectBevacizumab
dc.subjectRadiological weapon
dc.subjectRadiation therapy
dc.subjectBrain metastasis
dc.subjectSurgical oncology
dc.subjectNuclear medicine
dc.subjectRadiology
dc.subjectSurgery
dc.subjectInternal medicine
dc.subjectChemotherapy
dc.subjectMetastasis
dc.subjectCancer
dc.subject.sdg3
dc.titleClinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5042455431
local.authorid.openalexA5075123195

Dosyalar

Koleksiyonlar

Publications